Anticancer Effects of Niclosamide in Human GlioblastomaAnja Wieland, Björn Scheffler, Rolf Fimmers et al.|Clinical Cancer Research|2013Cited by 161
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PETSied Kebir, Ulrich Herrlinger, Rolf Fimmers et al.|Clinical Cancer Research|2015Cited by 126
Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in GlioblastomaMartin Glas, Björn Scheffler, Christoph Coch et al.|Stem Cells|2013Cited by 74
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade gliomaSied Kebir, Martin Glas, Zain Khurshid et al.|Oncotarget|2016Cited by 73
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human GlioblastomaRoman Reinartz, Björn Scheffler, Shanshan Wang et al.|Clinical Cancer Research|2016Cited by 72